LCP1 Antikörper

Produktnummer ABIN3026153

Produktdetails anti-LCP1 Antikörper

Target: LCP1 (Lymphocyte Cytosolic Protein 1 (LCP1))

Reaktivität: Human Herpesvirus 5 (HHV-5)

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser LCP1 Antikörper ist unkonjugiert

Applikation: ELISA, Immunofluorescence (IF), Immunocytochemistry (ICC)

Aufreinigung: Protein G affinity chromatography

Immunogen: Recombinant Cytomegalovirus p65 protein was used as the immunogen for this PP65 antibody.

Klon: CMV101

Isotyp: IgG1 kappa

Anwendungsinformationen

Applikationshinweise: The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the PP65 antibody to be titered up or down for optimal performance.\. ELISA: order BSA-free format for coating,Immunocytochemistry (Acetone or paraformaldehyde fixed): 0.5-1 μg/mL for 30 min,IF: 0.5-1 μg/mL

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Konservierungsmittel: Azide free

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store the PP65 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).

Details zu LCP1

Target: LCP1 (Lymphocyte Cytosolic Protein 1 (LCP1))

Andere Bezeichnung: PP65 (LCP1 Produkte)

Synonyme: CP64 antikoerper, L-PLASTIN antikoerper, LC64P antikoerper, LPL antikoerper, PLS2 antikoerper, cb245 antikoerper, fj24b12 antikoerper, wu:fj24b12 antikoerper, cp64 antikoerper, l-plastin antikoerper, lc64p antikoerper, lpl antikoerper, pls2 antikoerper, plastin-2 antikoerper, AW536232 antikoerper, D14Ertd310e antikoerper, LCP-1 antikoerper, Pls2 antikoerper, pp65 antikoerper, lymphocyte cytosolic protein 1 antikoerper, lymphocyte cytosolic protein 1 (L-plastin) antikoerper, lymphocyte cytosolic protein 1 (L-plastin) S homeolog antikoerper, lower matrix protein; involved in immune regulation antikoerper, LCP1 antikoerper, lcp1 antikoerper, lcp1.S antikoerper, Lcp1 antikoerper, UL83 antikoerper

Hintergrund: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.